Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT

European Journal of Heart Failure

Volumn 16, Issue 5, 2014, Pages 560-565

  Skali, Hicham ^a   Dwyer, Edward M ^b   Goldstein, Robert ^c   Haigney, Mark ^c   Krone, Ronald ^d   Kukin, Marrick ^e   Lichstein, Edgar ^f   McNitt, Scott ^g   Moss, Arthur J ^g   Pfeffer, Marc A ^a   Solomon, Scott D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^f MAIMONIDES MEDICAL CENTER   (United States)

^g UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Clinical trials; Endpoint; Heart failure; Outpatient

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HEART FAILURE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SYMPTOMATOLOGY; TREATMENT RESPONSE; AGE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; DISEASE COURSE; HEART MUSCLE ISCHEMIA; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES;

AGE FACTORS; AGED; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; INPATIENTS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OUTPATIENTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 84899472608     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.71     Document Type: Article

References (14)

1. Solomon SD, Dobson J, Pocock SJ, Skali H, McMurray JJV, Granger CB, Yusuf S, Swedberg KB, Young JB, Michelson EL, Pfeffer MA,. Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity CHARM Investigators. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 2007; 116: 1482-1487.
2. Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO,. Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol 2013; 61: 391-403.
3. O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC,. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 2008; 156: 662-673.
4. Pfeffer MA, Swedberg KB, Granger CB, Held P, McMurray JJV, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock SJ.,. CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003; 362: 759-766.
5. Cohn JN, Tognoni G,. Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001; 345: 1667-1675.
6. Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg KB, Shi H, Vincent J, Pocock SJ, Pitt B, EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011; 364: 11-21.
7. Collins SP, Pang PS, Fonarow GC, Yancy CW, Bonow RO, Gheorghiade M,. Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization. J Am Coll Cardiol 2013; 61: 121-126.
8. Desai AS, Stevenson LW,. There must be a better way: piloting alternate routes around heart failure hospitalizations. J Am Coll Cardiol 2013; 61: 127-130.
9. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NAM, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W,. MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338.
10. Goldenberg I, Hall WJ, Beck CA, Moss AJ, Barsheshet A, McNitt S, Polonsky S, Brown MW, Zareba W,. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy. J Am Coll Cardiol 2011; 58: 729-737.
11. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM,. Comparison of Medical Therapy Pacing and Defibrillation in Heart Failure COMPANION Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
12. Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN,. African-American Heart Failure Trial Investigators. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 2004; 351: 2049-2057.
13. Curtis AB, Worley SJ, Adamson PB, Chung ES, Niazi I, Sherfesee L, Shinn T, Sutton MSJ,. Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block (BLOCK HF) Trial Investigators. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med 2013; 368: 1585-1593.
14. Ezekowitz JA, Bakal JA, Kaul P, Westerhout CM, Armstrong PW,. Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failure. Eur J Heart Fail 2008; 10: 308-314.